| Literature DB >> 30951604 |
Hanna Lotzke1, Helena Brisby2, Annelie Gutke3, Olle Hägg4, Max Jakobsson5, Rob Smeets6, Mari Lundberg7.
Abstract
BACKGROUND: Prehabilitation programs have led to improved postoperative outcomes in several surgical contexts, but there are presently no guidelines for the prehabilitation phase before lumbar fusion surgery.Entities:
Mesh:
Year: 2019 PMID: 30951604 PMCID: PMC6665875 DOI: 10.1093/ptj/pzz020
Source DB: PubMed Journal: Phys Ther ISSN: 0031-9023
Figure 1.Schematic overview of the cognitive-behavioral fear-avoidance model, part of the underlying theoretical framework for the present study.
Figure 2.Schematic overview of the active prehabilitation intervention. PHODA = The Photographs Series of Daily Activities.
Figure 3.An overview of outcome measures and the different time points for baseline and follow-up assessments. EQ5D = European Quality of Life 5 Dimensions Questionnaire; GT3X+ = ActiGraph GT3X+ (ActiGraph, Pensacola, FL, USA); HADS = Hospital Anxiety and Depression Scale; ODI = Oswestry Disability Index 2.0; PCS = Pain Catastrophizing Scale; PSFS = Patient-Specific Functional Scale; QoL, quality of life; SEES = Self-Efficacy for Exercise Scale; TSK = Tampa Scale for Kinesiophobia; VAS = visual analogue scale.
Patient Characteristics of All Participants, Baseline Data
| Characterictic | All Patients (n = 118) | Active Intervention (n = 59) | Conventional Care (n = 59) |
|---|---|---|---|
| Mean [SD] age, y | 45.7 [8.3] | 44.8 [8.2] | 46.7 [8.5] |
| Sex (men/women) | 55/63 | 26/33 | 29/30 |
| Mean [SD] body mass index | 26.3 [3.7] | 26.3 [3.9] | 26.4 [3.4] |
| Smoking, n (%) | 8 (6.8) | 3 (5.1) | 5 (8.5) |
| Missing data, n (%) | 1 (0.8) | 1 (1.7) | 0 (0.0) |
| Education, n (%) | |||
| Elementary school | 7 (5.9) | 1 (1.7) | 6 (10.2) |
| High school | 51 (43.2) | 24 (40.7) | 27 (45.8) |
| University | 42 (35.6) | 23 (39.0) | 19 (32.2) |
| Vocational education | 17 (14.4) | 11 (18.6) | 6 (10.2) |
| Missing data | 1 (0.8) | 0 (0.0) | 1 (1.7) |
| Sick leave, n (%) | |||
| No sick leave | 75 (63.6) | 39 (66.1) | 36 (61.0) |
| Full-time | 25 (21.2) | 13 (22.0) | 12 (20.3) |
| Part-time | 16 (13.6) | 7 (11.9) | 9 (15.3) |
| Missing data | 2 (1.7) | 0 (0.0) | 2 (3.4) |
| Previous lumbar spine surgery, n (%) | |||
| 0 occasion (no previous back surgery) | 108 (91.5) | 55 (93.2) | 53 (89.8) |
| 1 occasion | 7 (5.9) | 4 (6.8) | 3 (5.1) |
| 2 occasions | 3 (2.5) | 0 (0.0) | 3 (5.1) |
| Pain duration, back > 2 y, n (%) | 87 (73.7) | 41 (34.7) | 46 (39.0) |
| Pain duration, leg > 2 y, n (%) | 52 (44.1) | 28 (47.5) | 24 (40.7) |
| Missing data | 1 (0.8) | 1 (1.7) | 0 (0.0) |
| Comorbidity, n (%) | 13 (11.0) | 6 (10.2) | 7 (11.9) |
| Surgical procedure, n (%) | |||
| Instrumented posterior fusion | 103 (87.3) | 53 (89.8) | 50 (84.7) |
| Instrumented anterior interbody fusion | 1 (0.8) | 1 (1.7) | 0 (0.0) |
| Instrumented combined posterior and interbody fusion | 4 (3.4) | 0 (0.0) | 4 (6.8) |
| Did not go through fusion surgery | 10 (8.5) | 5 (8.5) | 5 (8.5) |
| Fusion levels, n (%) | |||
| 1 level | 62 (57.4) | 32 (59.3) | 30 (55.6) |
| 2 level | 41 (38.0) | 20 (37.0) | 21 (38.9) |
| 3 level | 5 (4.2) | 2 (3.7) | 3 (5.6) |
Body mass index measured in kg/m2.
Figure 4.Flowchart of the included patients according to the format of the CONSORT Statement.
Baseline Scores, Change Scores (From Baseline), and Hedges Effect Sizes for Between-Group Differences Between Active Intervention and Conventional Care in All Patients by Intention-to-Treat Analysis
| Measure | Group or Parameter | Mean (95% CI) for: | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline Score | Change Score | | ||||||||
| From Baseline to 1 wk Before Surgery | From Baseline to 3 wk After Surgery | From Baseline to 8 wk After Surgery | From Baseline to 3 mo After Surgery | From Baseline to 6 mo After Surgery | Group Effect | Time Effect | Group × Time Interaction | |||
| Disability (ODI) | Active intervention | 35.7 (32.3–39.0) | 0.8 (−3.7 to 5.3) | 4.1 (−2.2 to 10.4) | −10.8 (−16.0 to −5.6) | −13.4 (−18.4 to −8.3) | −14.5 (−19.8 to −9.3) | .98 | < .001 | .16 |
| Conventional care | 38.0 (35.1–40.9) | 2.9 (−1.5 to 7.3) | 2.3 (−3.9 to 8.5) | −8.6 (−13.6 to −3.6) | −12.6 (−17.5 to −7.8) | −17.5 (−22.7 to −12.4) | ||||
| Between-group ES | 0.13 (−0.26 to 0.51) | −0.08 (−0.47 to 0.31) | 0.12 (−0.27 to 0.50) | 0.04 (−0.34 to 0.43) | −0.16 (−0.55 to 0.23) | |||||
| Pain intensity in back (VAS) | Active intervention | 57.3 (51.7 to 62.9) | −1.0 (−5.8 to 3.7) | −13.6 (−21.1 to −6.1) | −28.3 (−34.4 to −22.2) | −30.8 (−37.0 to −24.7) | −29.2 (−36.7 to −21.7) | .99 | < .001 | .19 |
| Conventional care | 65.0 (61.0–68.9) | 2.5 (−2.1 to 7.1) | −19.6 (−27.2 to −12.0) | −23.1 (−29.1 to −17.1) | −30.7 (−36.7 to −24.8) | −31.8 (−39.2 to −24.4) | ||||
| Between-group ES | 0.21 (−0.18 to 0.59) | −0.22 (−0.62 to 0.17) | 0.24 (−0.16 to 0.63) | 0 (−0.38 to 0.39) | −0.10 (−0.49 to 0.29) | |||||
| Pain intensity in leg (VAS) | Active intervention | 37.3 (29.3–45.3) | 3.0 (−10.9 to 17.0) | −16.6 (−30.7 to −2.6) | −19.4 (−32.7 to −6.0) | −24.4 (−37.2 to −11.6) | −17.6 (−30.9 to −4.2) | .47 | < .001 | .90 |
| Conventional care | 33.5 (26.3–40.7) | −1.3 (−15.1 to 12.4) | −16.5 (−30.5 to −2.5) | −19.0 (−32.2 to −5.8) | −26.2 (−38.8 to −13.6) | −21.6 (−34.8 to −8.4) | ||||
| Between-group ES | −0.09 (−0.47 to 0.30) | 0.00 (−0.39 to 0.40) | 0.01 (−0.39 to 0.40) | −0.04 (−0.43 to 0.35) | −0.08 (−0.47 to 0.31) | |||||
| Pain catastrophizing (PCS) | Active intervention | 22.5 (20.5–24.4) | −4.4 (−6.4 to −2.3) | −10.1 (−12.0 to −8.1) | −11.3 (−13.2 to −9.3) | −10.8 (−12.5 to −9) | −11.8 (−13.8 to −9.8) | .47 | < .001 | .20 |
| Conventional care | 23.1 (20.9–25.3) | −2.2 (−4.3 to −0.2) | −10.3 (−12.3 to −8.3) | −9.4 (−11.3 to −7.5) | −11.3 (−12.9 to −9.6) | −11.6 (−13.6 to −9.7) | ||||
| Between-group ES | 0.29 (−0.11 to 0.69) | −0.03 (−0.43 to 0.36) | 0.27 (−0.12 to 0.67) | −0.08 (−0.47 to 0.30) | 0.02 (−0.37 to 0.42) | |||||
| Fear of movement (TSK) | Active intervention | 37.8 (35.6–40.1) | −3.4 (−5.0 to −1.8) | −3.4 (−5.1 to −1.7) | −5.2 (−7.0 to −3.4) | −5.3 (−7.3 to −3.4) | −7.8 (−9.5 to −6.0) | .79 | < .001 | .22 |
| Conventional care | 38.5 (36.4–40.7) | −1.7 (−3.3 to −0.1) | −4.2 (−5.9 to −2.5) | −5.8 (−7.5 to −4.2) | −6.3 (−8.1 to −4.5) | −8.3 (−10.1 to −6.6) | ||||
| Between-group ES | 0.30 (−0.10 to 0.70) | −0.13 (−0.53 to 0.27) | −0.10 (−0.50 to 0.30) | −0.14 (−0.53 to 0.25) | −0.09 (−0.49 to 0.3) | |||||
| Self-efficacy for exercise (SEES) | Active intervention | 61.5 (56.4–66.6) | 0.6 (−6.1 to 7.3) | 6.8 (−0.5 to 14.2) | 5.3 (−1.6 to 12.1) | 6.1 (−0.8 to 12.9) | 4.9 (−2.5 to 12.4) | .54 | .02 | .30 |
| Conventional care | 60.8 (55.4–66.3) | −0.4 (−6.9 to 6.1) | 0.5 (−6.7 to 7.7) | 6.6 (0.0 to 13.1) | 5.1 (−1.4 to 11.6) | 3.4 (−3.8 to 10.6) | ||||
| Between-group ES | 0.04 (−0.35 to 0.44) | 0.25 (−0.16 to 0.65) | −0.05 (−0.45 to 0.34) | 0.04 (−0.35 to 0.43) | 0.06 (−0.34 to 0.46) | |||||
| Anxiety (HADS) | Active intervention | 6.9 (5.9–7.9) | −0.3 (−1.4 to 0.8) | −2.2 (−3.1 to −1.2) | −2.3 (−3.3 to −1.3) | −2.5 (−3.4 to −1.6) | −2.7 (−3.5 to −1.8) | .43 | < .001 | .85 |
| Conventional care | 6.3 (5.5–7.2) | 0.3 (−0.7 to 1.4) | −1.8 (−2.7 to −0.9) | −1.7 (−2.7 to −0.8) | −2.4 (−3.3 to −1.6) | −2.6 (−3.5 to −1.8) | ||||
| Between-group ES | 0.16 (−0.23 to 0.56) | 0.11 (−0.30 to 0.51) | 0.17 (−0.23 to 0.58) | 0.03 (−0.37 to 0.42) | 0.01 (−0.39 to 0.41) | |||||
| Depressed mood (HADS) | Active intervention | 5.1 (4.2–6) | −0.5 (−1.5 to 0.6) | −1.0 (−2.1 to 0.1) | −1.3 (−2.4 to −0.2) | −1.6 (−2.7 to −0.6) | −1.8 (−2.9 to −0.8) | .84 | < .001 | .34 |
| Conventional care | 5.7 (4.8–6.6) | 0.5 (−0.6 to 1.5) | −1.0 (−2.0 to 0.1) | −1.4 (−2.4 to −0.3) | −1.8 (−2.8 to −0.8) | −2.1 (−3.1 to −1.1) | ||||
| Between-group ES | 0.25 (−0.14 to 0.65) | 0.00 (−0.40 to 0.40) | −0.02 (−0.42 to 0.37) | −0.05 (−0.44 to 0.34) | −0.07 (−0.47 to 0.33) | |||||
| Health-related quality of life (EQ-5D Index) | Active intervention | 0.51 (0.44–0.58) | 0.09 (0.02–0.16) | 0.02 (−0.05 to 0.1) | 0.19 (0.13–0.25) | 0.20 (0.14–0.25) | 0.21 (0.15–0.27) | .52 | <.001 | .01 |
| Conventional care | 0.47 (0.40–0.55) | −0.05 (−0.12 to 0.02) | 0.07 (0–0.14) | 0.14 (0.08–0.20) | 0.20 (0.15–0.26) | 0.26 (0.21–0.32) | ||||
| Between-group ES | 0.57 (0.16–0.98) | −0.18 (−0.57 to 0.22) | 0.23 (−0.16 to 0.63) | −0.03 (−0.42 to 0.35) | −0.25 (−0.64 to 0.14) | |||||
| Health-related quality of life (EQ-5D VAS) | Active intervention | 46.1 (41.6–50.7) | −1.6 (−9.0 to 5.8) | 5.4 (−3.1 to 14.0) | 18.8 (11.3–26.2) | 24.2 (17.4–31.1) | 23.2 (15.9–30.6) | .50 | < .001 | .53 |
| Conventional care | 46.1 (41.5–50.8) | −2.3 (−9.4 to 4.9) | 10.7 (2.4–19.1) | 20.0 (12.9–27.2) | 24.1 (17.5–30.6) | 26.4 (19.2–33.5) | ||||
| Between-group ES | 0.02 (−0.37 to 0.41) | −0.18 (−0.58 to 0.22) | −0.05 (−0.44 to 0.35) | 0.01 (−0.38 to 0.4) | −0.12 (−0.52 to 0.27) | |||||
| Patient-reported functioning (PSFS) | Active intervention | 2.8 (2.4–3.3) | 0.2 (−0.3 to 0.7) | 0.2 (−0.5 to 0.9) | 1.5 (0.8–2.2) | 2.0 (1.3–2.6) | 2.9 (2.2–3.6) | .13 | < .001 | .83 |
| Conventional care | 2.9 (2.4–3.5) | −0.2 (−0.7 to 0.3) | −0.1 (−0.8 to 0.5) | 0.7 (0.1–1.4) | 1.3 (0.6–1.9) | 2.5 (1.8–3.2) | ||||
| Between-group ES | 0.23 (−0.19 to 0.65) | 0.15 (−0.27 to 0.57) | 0.35 (−0.06 to 0.76) | 0.30 (−0.10 to 0.70) | 0.17 (−0.25 to 0.59) | |||||
| Steps/d | Active intervention | 7811.8 (7088.3–8535.4) | −88.5 (−687.2 to 510.2) | 180.5 (−421.7 to 782.7) | .77 | .91 | .20 | |||
| Conventional care | 7175.2 (6544.3–7806) | 42.3 (−549.3 to 633.8) | −183.8 (−780.1 to 412.6) | |||||||
| Between-group ES | −0.09 (−0.50 to 0.32) | 0.25 (−0.16 to 0.66) | ||||||||
| Time spent in MVPA, min/d (total accumulated) | Active intervention | 29.9 (24.8–35) | 3.7 (−1.3 to 8.8) | 2.5 (−2.2 to 7.3) | .22 | .07 | .33 | |||
| Conventional care | 26.5 (21.3–31.8) | 1.7 (−3.3 to 6.7) | −2.2 (−6.8 to 2.4) | |||||||
| Between-group ES | 0.16 (−0.25 to 0.57) | 0.42 (0.00–0.83) | ||||||||
| Time spent in light physical activity, min/d | Active intervention | 276.4 (254.3–298.4) | −23.6 (−43.3 to −3.9) | −7.1 (−28.8 to 14.6) | .80 | .03 | .98 | |||
| Conventional care | 279.8 (264.2–295.5) | −27.1 (−46.7 to −7.5) | −10.3 (−31.8 to 11.3) | |||||||
| Between-group ES | 0.07 (−0.33 to 0.48) | 0.06 (−0.35 to 0.47) | ||||||||
| Time spent sedentary, min/d | Active intervention | 550.1 (524.0–576.2) | 27.9 (−13.9 to 69.8) | 19 (−24.9 to 63) | .39 | .82 | .23 | |||
| Conventional care | 543.3 (521.5–565.1) | 27.8 (−12.8 to 68.3) | 40.9 (−1.8 to 83.7) | |||||||
| Between-group ES | 0.00 (−0.41 to 0.4) | 0.21 (−0.21 to 0.62) | ||||||||
| 5-min walk, m | Active intervention | 427.5 (405.6–449.3) | 47.0 (−0.3 to 94.2) | 58.8 (10.7–106.8) | .75 | .01 | .62 | |||
| Conventional care | 409.9 (389.9–429.9) | 41.5 (−4.8 to 87.9) | 58.3 (10.9–105.6) | |||||||
| Between-group ES | 0.05 (−0.35 to 0.45) | 0 (−0.40 to 0.41) | ||||||||
| ∼15-m (50-ft) walk, s | Active intervention | 8.9 (8.2–9.6) | −0.9 (−1.6 to −0.1) | −0.9 (−1.7 to −0.1) | .57 | .36 | .39 | |||
| Conventional care | 9.6 (8.9–10.3) | −1.0 (−1.7 to to −0.2) | −1.1 (−1.9 to −0.4) | |||||||
| Between-group ES | −0.04 (−0.44 to 0.36) | −0.12 (−0.53 to 0.28) | ||||||||
| Timed “Up & Go” Test, s | Active intervention | 8.0 (7.1–8.9) | −1.5 (−2.1 to −0.8) | −1.7 (−2.4 to −1.1) | .44 | < .001 | .21 | |||
| Conventional care | 7.8 (7.3–8.3) | −1.2 (−1.8 to −0.6) | −1.7 (−2.3 to −1) | |||||||
| Between-group ES | 0.19 (−0.21 to 0.59) | 0.05 (−0.35 to 0.46) | ||||||||
| 1-min stair climb, steps | Active intervention | 107.1 (100.3–113.9) | 15.2 (10.6–19.8) | 19.2 (13.7–24.6) | .71 | < .001 | .37 | |||
| Conventional care | 101.1 (95.4–106.8) | 15.0 (10.6–19.5) | 21.6 (16.2–27) | |||||||
| Between-group ES | 0.02 (−0.38 to 0.42) | −0.18 (−0.59 to 0.23) | ||||||||
| One-Leg Stand test: eyes open, s | Active intervention | 44.1 (38.6–49.6) | 5.1 (0.3–9.8) | 7.0 (3.0–11.1) | .97 | .016 | .29 | |||
| Conventional care | 38.7 (33.1–44.3) | 3.5 (−1.2 to 8.1) | 8.4 (4.3–12.6) | |||||||
| Between-group ES | 0.14 (−0.26 to 0.54) | −0.14 (−0.54 to 0.27) | ||||||||
| One-Leg Stand test: eyes closed, s | Active intervention | 4.7 (3.0–6.4) | 0.5 (−0.7 to 1.7) | 2.1 (−0.1 to 4.2) | .14 | .34 | .49 | |||
| Conventional care | 2.8 (2.3–3.2) | −0.1 (−1.3 to 1.1) | 0.1 (−2.1 to 2.3) | |||||||
| Between-group ES | 0.23 (−0.17 to 0.63) | 0.36 (−0.05 to 0.77) | ||||||||
Fixed factors used in the linear mixed model analysis: treatment group, time, group × time interaction term, confounding factors (baseline values of depression, baseline steps/d, and sex), and the baseline value of the dependent variable; random factor: treatment center. EQ-5D = European Quality of Life 5 Dimensions Questionnaire; ES = effect size; HADS = Hospital Anxiety and Depression Scale; MVPA = moderate-to-vigorous–intensity physical activity; ODI = Oswestry Disability Index 2.0; PCS = Pain Catastrophizing Scale; PSFS = Patient-Specific Functional Scale; SEES = Self-Efficacy for Exercise Scale; TSK = Tampa Scale for Kinesiophobia; VAS = visual analogue scale.
The change score reached the minimal important change 8 wk after surgery.
In the model for anxiety, depression was not used as a confounding factor because of multicolinearity.
In the model for time spent in MVPA/d, steps/d was not used as a confounding factor because of multicolinearity.
Figure 5.Graphs of change scores in physical activity measured as (A) minutes per day in moderate-to-vigorous physical activity, (B) steps per day, and (C) minutes per day spent sedentary, with 95% confidence intervals.
Reference Values and Minimal Important Changes of the Outcome Measures
| Outcome | Reference Values | Minimal Important Change |
|---|---|---|
| Disability (ODI) (0–100) | 0–20: “minimal disability”; 21–40: “moderate disability”; 41–60: “severe disability”; 61–80: “crippled”; 81–100: “bed-bound or exaggerating their symptoms” (Fairbank et al[ | −8.0 points (Hägg et al[ |
| Pain intensity—back (VAS) (0–100) | 0–4 mm: “no pain”; 5–44 mm: “mild pain”; 45–74 mm: “moderate pain”; and 75–100 mm: “severe pain” (Jensen et al[ | −15 mm (Asher et al[ |
| Pain intensity—leg (VAS) (0–100) | 0–4 mm: “no pain”; 5–44 mm: “mild pain”; 45–74 mm: “moderate pain”; and 75–100 mm: “severe pain” (Jensen et al[ | −17 mm (Asher et al[ |
| Pain catastrophizing (PCS) (0–52) | Cutoff point for pain catastrophizing: ≥ 20 (Sullivan et al[ | −38% from baseline (Scott et al[ |
| Fear of movement (TSK) (17–68) | Cutoff point for kinesiophobia ≥ 37 (Lundberg[ | −6.0 points (Monticone et al[ |
| Self-efficacy for exercise (SEES) (0–90) | N/A | N/A |
| Anxiety (HADS) (0–21) | Normative data, United Kingdom: 6.2 (Breeman et al[ | −1.5 points (Lindbäck et al.[ |
| Depressed mood (HADS) (0–21) | Normative data, United Kingdom: 4.0 (Breeman et al[ | −1.5 points (Lindbäck et al.[ |
| Health-related quality of life (EQ-5D index) (−0.59 to 1.00) | Normative data, United Kingdom, age 45–54: 0.85 (Szende et al[ | 0.17 points (Johnsen et al[ |
| Health-related quality of life (EQ-5D VAS) (0–100) | Normative data, Sweden, age 45–54: 83.7 (Szende et al[ | 4.4 points (Asher et al[ |
| Patient-reported functioning (PSFS) (0–10) | N/A | 2.0 points (Maughan and Lewis[ |
| Steps/d | < 5000: “sedentary”; 5000–7499: “low active”; 7500–9999: “somewhat active”; 10,000–12,499: “active”; ≥ 12,500: “highly active” (Tudor-Locke et al[ | N/A |
| Time spent in MVPA per day | Normative data, Sweden, age 40–59: 33.3 min/d (Hagströmer et al[ | N/A |
| Time spent in light physical activity per day | N/A | N/A |
| Time spent sedentary per day | N/A | N/A |
| 5-min walk | Pain-free sample, United States: 518.2 m (Simmonds et al[ | 21.4 m (Andersson et al[ |
| 50-ft walk | Pain-free sample, United States: 8.4 s (Simmonds et al[ | −0.7 s (Andersson et al[ |
| Timed “Up & Go” Test | Pain-free sample: 5.2 s (Simmonds et al[ | −3.4 s (Gautschi et al[ |
| 1-min stair climbing | N/A | 14.5 steps (Andersson et al[ |
| One-Leg Stand Test: eyes open | N/A | N/A |
| One-Leg Stand Test: eyes closed | N/A | N/A |
EQ-5D = European Quality of Life 5 Dimensions Questionnaire; HADS = Hospital Anxiety and Depression Scale; MVPA = moderate-to-vigorous–intensity physical activity; N/A = not applicable; ODI = Oswestry Disability Index 2.0; PCS = Pain Catastrophizing Scale; PSFS = Patient-Specific Functional Scale; SEES = Self-Efficacy for Exercise Scale; TSK = Tampa Scale for Kinesiophobia; VAS = visual analogue scale.